{"schema_version":"secwatch.filing_event.v1","accession":"0000072331-25-000053","form_type":"8-K","ticker":"NDSN","cik":"0000072331","company_name":"NORDSON CORP","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.106774+00:00","generated_at":"2026-05-20T09:10:56.733182+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M","bullets":["Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.","Reported EPS $1.97 vs $2.05 prior year; adjusted EPS $2.42 (+3% YoY) above guidance midpoint.","Advanced Technology Solutions organic sales +18% YoY; Medical & Fluid Solutions +20% (incl. Atrion).","Q3 guidance: sales $710-$750M, adjusted EPS $2.55-$2.75 per diluted share.","Backlog grew ~5% sequentially; company repurchased $85M in shares during the quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0000072331-25-000053","json":"https://secwatch.observer/filing/0000072331-25-000053.json","markdown":"https://secwatch.observer/filing/0000072331-25-000053.md","text":"https://secwatch.observer/filing/0000072331-25-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/0000072331-25-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/72331/000007233125000053/ndsn-20250528.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T09:10:56.733182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}